Skip to main content
. 2024 Mar 8;150(3):115. doi: 10.1007/s00432-024-05627-3

Fig. 5.

Fig. 5

Treatment concordance between DSS and MDT. a Overall treatment concordance rates between the therapeutic recommendation given by the MDT and the treatment recommendation given by DSS for malignant melanoma. Overall concordance was 97%. b Treatment concordance rates according to malignant melanoma stages I, II, III, and IV were 100%, 95%, 98%, and 100%, respectively